소아 아토피천식 환자에서 메타콜린 PC20와 천식 조절 상태 사이의 연관성
Relationship between methacholine PC20 level and asthma control status among pediatric patients with atopic asthma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Although methacholine PC20 helps clinicians to identify asthma, there are practical limitations in using methacholine PC20 to assess asthma control. We assessed the relationship between methacholine PC20 levels and asthma control status in child patients with atopic asthma. Methods: We enrolled 153 children of 8 to 15 years of age with atopic asthma and measured methacholine PC20 of these children when their asthma was controlled. We followed up these patients for more than 2 years with measurements of asthma control score, lung function, bronchodilator response (BDR), and fractional exhaled nitric oxide (FeNO). Results: The geometric mean of methacholine PC20 in the study population was 2.81 mg/mL. Lower methacholine PC20 was found to be associated with lower lung function, higher rate of BDR greater than 12%, higher level of BDR, higher rate of FeNO levels greater than 23 ppb, higher FeNO, higher numbers of asthma aggravation per year, and higher rate of asthma control test scores of 19 or less. Conclusion: These data provide evidences that the degree of methacholine PC20 is linked to disease severity in children with atopic asthma. Thus, regular and close monitoring of asthma control should be required for patients with lower levels of methacholine PC20.
Abstract
Purpose: Although methacholine PC20 helps clinicians to identify asthma, there are practical limitations in using methacholine PC20 to assess asthma control. We assessed the relationship between methacholine PC20 levels and asthma control status in child patients with atopic asthma. Methods: We enrolled 153 children of 8 to 15 years of age with atopic asthma and measured methacholine PC20 of these children when their asthma was controlled. We followed up these patients for more than 2 years with measurements of asthma control score, lung function, bronchodilator response (BDR), and fractional exhaled nitric oxide (FeNO). Results: The geometric mean of methacholine PC20 in the study population was 2.81 mg/mL. Lower methacholine PC20 was found to be associated with lower lung function, higher rate of BDR greater than 12%, higher level of BDR, higher rate of FeNO levels greater than 23 ppb, higher FeNO, higher numbers of asthma aggravation per year, and higher rate of asthma control test scores of 19 or less. Conclusion: These data provide evidences that the degree of methacholine PC20 is linked to disease severity in children with atopic asthma. Thus, regular and close monitoring of asthma control should be required for patients with lower levels of methacholine PC20.
참고문헌 (31)
- Busse WW, "The relationship of airway hyperresponsiveness and airway inflammation: airway hyperresponsiveness in asthma: its measurement and clinical significance", Chest, 138(2 Suppl), pp.4S~10S (2010)
- Cockcroft DW, "Mechanisms of airway hyperresponsiveness", J Allergy Clin Immunol, 118, pp.551~559 (2006)
- O’Byrne PM, "Provoked models of asthma: what have we learnt?", Clin Exp Allergy, 39, pp.181~192 (2009)
- Sumino K, "Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications", J Allergy Clin Immunol, 130, pp.69~75 (2012)
- Cockcroft D, "Direct and indirect challenges in the clinical assessment of asthma", Ann Allergy Asthma Immunol, 103, pp.363~369 (2009)
- Sont JK, "Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids", Thorax, 51, pp.496~502 (1996)
- Rosi E, "Sputum analysis,bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis", J Allergy Clin Immunol, 103(2 Pt 1), pp.232~237 (1999)
- Expert panel report 3: guidelines for the diagnosis and management of asthma, "National Heart, Lung and Blood Institute. National asthma education and prevention program", Bethesda: National Heart, Lung and Blood Institute, ~ (2012)
- Nathan RA, "Development of the asthma control test: a survey for assessing asthma control", J Allergy Clin Immunol, 113, pp.59~65 (2004)
- Liu AH, "Development and cross-sectional validation of the Childhood Asthma Control Test", J Allergy Clin Immunol, 119, pp.817~825 (2007)
- Hankinson JL, "Spirometric reference values from a sample of the general U.S. population", Am J Respir Crit Care Med, 159, pp.179~187 (1999)
- Miller MR, "Standardisation of spirometry", Eur Respir J, 26, pp.319~338 (2005)
- Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
- "Recommendations for standardized procedures for the on-line and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 160, pp.2104~2117 (1999)
- Cockcroft DW, "Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance", Chest, 138(2 Suppl), pp.18S~24S (2010)
- Weiss ST, "Relationship between increased airway responsiveness and asthma severity in the childhood asthma management program", Am J Respir Crit Care Med, 162, pp.50~56 (2000)
- Ichinose M, "Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre", Eur Respir J, 15, pp.248~253 (2000)
- De Meer G, "Bronchial responsiveness to adenosine 5’-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1)", Am J Respir Crit Care Med, 165, pp.327~331 (2002)
- Colon-Semidey AJ, "Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma", Pediatr Pulmonol, 30, pp.385~392 (2000)
- Synek M, "Cellular infiltration of the airways in asthma of varying severity", Am J Respir Crit Care Med, 154, pp.224~230 (1996)
- Szefler SJ, "Severe asthma: pathogenesis and clinical management" (1996), Marcel Dekker
- 서동인, "알레르기비염과 천식 소아에서의 기관지확장제 반응 및 기관지과민성과의 연관성", Allergy Asthma & Respiratory Diseases, 20(1), pp.59~67 (2010), 대한 소아알레르기 호흡기학회
- Short PM, "Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma", Lung, 189, pp.493~497 (2011)
- Langley SJ, "Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients", Ann Allergy Asthma Immunol, 91, pp.398~404 (2003)
- Crimi E, "Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma", Am J Respir Crit Care Med, 157, pp.4~9 (1998)
- Reid DW, "Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients", Respirology, 8, pp.479~486 (2003)
- Berlyne GS, "A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation", J Allergy Clin Immunol, 106, pp.638~644 (2000)
- Brightling CE, "Comparison of airway immunopathology of eosinophilic bronchitis and asthma", Thorax, 58, pp.528~532 (2003)
- Warke TJ, "Exhaled nitric oxide correlates with airway eosinophils in childhood asthma", Thorax, 57, pp.383~387 (2002)
- Woo SI, "Utility of fractional exhaled nitric oxide (F(E)NO) measurements in diagnosing asthma", Respir Med, 106, pp.1103~1109 (2012)